|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Rodriguez E and Lilenbaum RC: Small cell
lung cancer: past, present, and future. Curr Oncol Rep. 12:327–334.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackman DM and Johnson BE: Small-cell lung
cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755.
2011.
|
|
5
|
Mundy GR: Metastasis to bone: causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uy HL, Mundy GR, Boyce BF, et al: Tumor
necrosis factor enhances parathyroid hormone-related
protein-induced hypercalcemia and bone resorption without
inhibiting bone formation in vivo. Cancer Res. 57:3194–3199.
1997.
|
|
7
|
Cai Z, Chen Q, Chen J, et al: Monocyte
chemotactic protein 1 promotes lung cancer-induced bone resorptive
lesions in vivo. Neoplasia. 11:228–236. 2009.PubMed/NCBI
|
|
8
|
Han JH, Choi SJ, Kurihara N, Koide M, Oba
Y and Roodman GD: Macrophage inflammatory protein-1alpha is an
osteoclastogenic factor in myeloma that is independent of receptor
activator of nuclear factor kappaB ligand. Blood. 97:3349–3353.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miki T, Yano S, Hanibuchi M, Kanematsu T,
Muguruma H and Sone S: Parathyroid hormone-related protein (PTHrP)
is responsible for production of bone metastasis, but not visceral
metastasis, by human small cell lung cancer SBC-5 cells in natural
killer cell-depleted SCID mice. Int J Cancer. 108:511–515. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Zhou M, Gong M, et al: A novel
animal model for bone metastasis in human lung cancer. Oncol Lett.
3:802–806. 2012.PubMed/NCBI
|
|
11
|
Miki T, Yano S, Hanibuchi M and Sone S:
Bone metastasis model with multiorgan dissemination of human
small-cell lung cancer (SBC-5) cells in natural killer
cell-depleted SCID mice. Oncol Res. 12:209–217. 2000.PubMed/NCBI
|
|
12
|
Zhang H, Yano S, Miki T, et al: A novel
bisphosphonate minodronate (YM529) specifically inhibits osteolytic
bone metastasis produced by human small-cell lung cancer cells in
NK-cell depleted SCID mice. Clin Exp Metastasis. 20:153–159. 2003.
View Article : Google Scholar
|
|
13
|
Liu Y, Zhang N, Wang Y, et al: Zinc finger
E-box binding homeobox 1 promotes invasion and bone metastasis of
small cell lung cancer in vitro and in vivo. Cancer Sci.
103:1420–1428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Zhang Y, Min J, et al: Calcineurin
promotes proliferation, migration, and invasion of small cell lung
cancer. Tumour Biol. 31:199–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma NQ, Liu LL, Min J, et al: The effect of
down regulation of calcineurin Aα by lentiviral vector-mediated
RNAi on the biological behavior of small-cell lung cancer and its
bone metastasis. Clin Exp Metastasis. 28:765–778. 2011.
|
|
16
|
Jaseja M, Mergen L, Gillette K, Forbes K,
Sehgal I and Copié V: Structure-function studies of the functional
and binding epitope of the human 37 kDa laminin receptor precursor
protein. J Pept Res. 66:9–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi Y, Zhai H, Wang X, et al:
Multidrug-resistance-associated protein MGr1-Ag is identical to the
human 37-kDa laminin receptor precursor. Cell Mol Life Sci.
59:1577–1583. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Annabi B, Currie JC, Bouzeghrane M, et al:
Contribution of the 37-kDa laminin receptor precursor in the
anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.
Biochem Biophys Res Commun. 346:358–366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu L, Ning X, Sun L, et al: Involvement
of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in
gastric cancer cells. Mol Cell Biochem. 303:151–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Sun L, Zhang H, et al:
Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers
occurs via hypoxia-inducible-factor 1-dependent mechanism and
contributes to drug resistance. Int J Cancer. 124:1707–1715. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
23
|
Calbo J, van Montfort E, Proost N, et al:
A functional role for tumor cell heterogeneity in a mouse model of
small cell lung cancer. Cancer Cell. 19:244–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang F, Wang Q, Ye L, Feng Y and Zhang X:
Hepatitis B virus X protein upregulates expression of calpain small
subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. J Med
Virol. 82:920–928. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bogenrieder T and Herlyn M: Axis of evil:
molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roodman GD: Biology of osteoclast
activation in cancer. J Clin Oncol. 19:3562–3571. 2001.PubMed/NCBI
|
|
28
|
Sone S and Yano S: Molecular pathogenesis
and its therapeutic modalities of lung cancer metastasis to bone.
Cancer Metastasis Rev. 26:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
|
